Navigation Links
Stemedica Completes Meeting with the FDA
Date:10/15/2009

lifornia.

For more information regarding Stemedica Cell Technologies, Inc. contact Dave McGuigan at dmcguigan at stemedica.com.

###

Read the full story at http://www.prweb.com/releases/stemedica-stem-cell/ischemic-stroke-FDA/prweb3053264.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy
2. The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. - First Clinical Trail Anticipated To Begin Early 2010
3. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
4. Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries
5. Stemedica Requests Pre-IND Meeting With FDA
6. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
7. Renowned Stem Cell Researcher Files Study Results With Stemedica
8. CIRM Completes Briefing Visit to Stemedica Cell Technologies
9. Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
10. Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer
11. Jennerex Completes Over-Subscribed Series C Financing for Aggregate Gross Proceeds of Over $5.5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stemedica Completes Meeting with the FDA
Stemedica Completes Meeting with the FDA
(Date:12/16/2009)... Hahnemann among the Best in the Nation ... Hospital proudly announces it has been granted Magnet(R) ... Magnet Recognition Program(R). Magnet(R) is one of the ... center can achieve, and places Hahnemann among the ... have achieved this prestigious distinction. ,, At 9:00 ...
(Date:12/16/2009)... Resources, one of the world,s leading research and ... that, according to responses from surveyed dermatologists, Centocor ... inhibitors) will capture 22 percent of the biologics ... moderate to severe psoriasis. Among these two agents, ... times as much patient share as briakinumab. ...
(Date:12/16/2009)... for the ultimate CHO cell culture supplement? InVitria has what ... cell culture media supplement that improves the growth and productivity ... culture performance, Zap-CHO is an animal free, well defined and ... ... Fort Collins, CO (PRWEB) December 16, 2009 -- Scientists working ...
(Date:12/15/2009)... MARINO, Calif., Dec. 15 Epeius Biotechnologies ... targeted genetic medicine, gained international validation of the ... Rexin-G , when scientists around the world rediscovered ... a major locus of cancer pathogenesis and disease ... therapies. Recently, scientists at the NIH National Cancer ...
Breaking Biology Technology:Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... , Introduction , ... , of the glycolytic pathway in crustaceans. This enzyme ... and the phosphorylation of ADP , to ATP. In ... in invertebrates, regulation of PK activity in response to changes ...
... Insulin is a peptide hormone which stimulates anabolic ... resulting in lowered blood glucose. It is used therapeutically , ... , on the market. Although insulin is ... often difficult to purify because of the harsh pH and denaturing , ...
... Agencourt offers sequencing services designed specifically for clients who ... and finishing. Agencourt , has many features that allow ... project turnaround including: Comprehensive genomic , ... High throughput, GLP-compliant facility , ...
Other Biology Technology:Purification of Two Isoforms of Pyruvate Kinase from Nordic Krill Using an UNO Q1 Column, Rev A 2Purification of Insulin on UNO S1 Column, Rev A 2cDNA Sequencing & Finishing 2
(Date:12/17/2009)... animal model showing that four commonly used chemotherapy drugs ... the condition could be partially reversed with the growth ... journal Cancer Investigation , the University of Rochester ... cancer survivors who experience a frustrating decline in cognitive ... , "It is not yet clear how our results ...
(Date:12/17/2009)... for another mass extinction like the previous five, each of ... on the planet, then North American mammals are one-fifth to ... Berkeley, and Pennsylvania State University analysis. , Many scientists warn ... both the result of human activity is ... Five" that have occurred over the past 450 million years, ...
(Date:12/17/2009)... to fund reduced emissions from deforestation may generate ... target sites that are both carbon and biodiversity-rich. ... the journal Conservation Letters , also warns ... parts of East Africa unless safeguards are followed. ... Deforestation and forest Degradation (REDD) might also displace ...
Breaking Biology News(10 mins):UR study reveals chemo's toxicity to brain, possible treatment 2UR study reveals chemo's toxicity to brain, possible treatment 3Study shows loss of 15-42 percent of mammals in North America 2Study shows loss of 15-42 percent of mammals in North America 3New report underlines multiple benefits but also new challenges to biodiversity-rich sites 2New report underlines multiple benefits but also new challenges to biodiversity-rich sites 3Show Your Best Summer Skin 50366 1Show Your Best Summer Skin 50366 2Golden Meditech Announces Financial Year 2008 09 Annual Results 50363 1Golden Meditech Announces Financial Year 2008 09 Annual Results 50363 2Golden Meditech Announces Financial Year 2008 09 Annual Results 50363 3Global Small Molecule Kinase Inhibitors Market to Reach 2416 2 Billion by 2015 According to a New Report by Global Industry Analysts Inc 12838 1Global Small Molecule Kinase Inhibitors Market to Reach 2416 2 Billion by 2015 According to a New Report by Global Industry Analysts Inc 12838 2Global Small Molecule Kinase Inhibitors Market to Reach 2416 2 Billion by 2015 According to a New Report by Global Industry Analysts Inc 12838 3
... Hospital have given investigators around the world free access ... Internet-based tool, called the mouse Brain Gene Expression Map ... of an organ ever developed, according to the St. ... scientists discover the genetic origins of brain cancers, which ...
... conducted by researchers from Scripps Research; the Genomics Research ... It is being published today in the journal Chemistry ... is currently the Ernest W. Hahn Chair in Chemistry ... the Scripps Research lab heading the study. He said ...
... better than to emulate a dragonfly. With four wings instead ... allows the bug to hover and even shift into reverse, ... Z. Jane Wang, professor of theoretical and applied mechanics at ... dynamics today (Feb. 19) at the annual meeting of the ...
Other Biology News:Powerful new tool for studying brain development 2Powerful new tool for studying brain development 3Powerful new tool for studying brain development 4Enzyme inhibitors block replication of SARS virus 2Scientist uses dragonflies to better understand flight 2
...
...
... OneSTrEP Protein Interaction Kit provides an ... method to isolate intact protein complexes. ... optimization or multiple purification steps, this ... selective StrepTactin Superflow Column for fast ...
Liquid. Phycoerythrin conjugate is in PBS, pH 7.4 containing 1% BSA and 0.1% sodium azide....
Biology Products: